Crescent Biopharma (CBIO) Property, Plant & Equipment (Net) Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Crescent Biopharma | 569.36 Mn | 380.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.91% |
| Dec 31, 2025 | 6.39% |
| Sep 30, 2025 | 3.40% |
| Jun 30, 2025 | -22.89% |
| Sep 30, 2023 | -32.77% |
| Jun 30, 2023 | -30.16% |
| Mar 31, 2023 | -28.24% |
| Dec 31, 2022 | -26.20% |
| Sep 30, 2022 | -23.81% |
| Jun 30, 2022 | -22.09% |
| Mar 31, 2022 | -20.09% |
| Dec 31, 2021 | -18.98% |
| Sep 30, 2021 | -8.75% |
| Jun 30, 2021 | 0.13% |
| Mar 31, 2021 | 2.41% |
| Dec 31, 2020 | 3.55% |
| Sep 30, 2020 | 3.12% |
| Jun 30, 2020 | 4.10% |
| Mar 31, 2020 | 12.66% |
| Dec 31, 2019 | 12.72% |
| Sep 30, 2019 | 12.76% |
| Jun 30, 2019 | 17.19% |
| Mar 31, 2019 | 20.48% |
| Dec 31, 2018 | 19.08% |